| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President
1 company
Spetzler David Baxley serves as a President at CAI. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $12.3M at current prices.
The biggest single holding is CAI (~$12.3M) as President. Net of sales, the recent Form 4 record there shows accumulation of 400 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | CAI Caris Life Sciences, Inc. | President | Buy | 400 | $23.85 | $9,540.00 | - | -17.0% | - |